eyenovia.com (EYEN) - Long-Term Debt to Capital Coefficient

This daily price chart for Eyenovia, Inc. (EYEN) reflects a metric currently standing at 0.00. Eyenovia, Inc. (EYEN) is implementing sustainable packaging standards and reducing production energy costs. The technology stack is based on the development of the Optejet smart sprayer, which utilizes AI for precise drug delivery. The business is currently transitioning to the commercial stage, expanding its distribution network across US clinics and attracting strategic partners.

Eyenovia, Inc. (EYEN) focuses on bringing innovative ophthalmological drug delivery systems to market. By analyzing the long-term debt-to-equity trend, an investor can see the ratio of liabilities exceeding one year to net assets. This metric determines the degree of financial leverage and the extent to which development depends on borrowed funds. For Eyenovia, Inc. (EYEN), this reflects the balance between regulatory costs and credit burden. A low ratio confirms capital stability during product commercialization.